Search Within

Sloan Kettering Institute Postdocs

  1. "Center for Molecular Imaging and Biotechnology (CMIB)"
Formats
  1. Journal Article (1972)
  2. Meeting Abstract (830)
  3. Review (89)
  4. Editorial (44)
  5. Research Letter (33)
  6. Conference Paper (31)
  7. Book Section (27)
  8. Miscellaneous (7)
  9. Correspondence (4)
  10. Book Whole (2)
  11. Guidelines (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (3040)
  2. GSK Faculty (2952)
  3. Sloan Kettering Institute Faculty (1601)
  4. Department of Medicine (1480)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1101)
  6. Tow Center for Developmental Oncology (TCDO) (1090)

More Groups

People
  1. Michael Berger (289)
  2. Nikolaus Schultz (272)
  3. Jason Lewis (266)
  4. Ross Levine (211)
  5. Charles Rudin (205)
  6. David Solit (163)

More People

Years
  1. 2025 (163)
  2. 2024 (213)
  3. 2023 (252)
  4. 2022 (333)
  5. 2021 (273)
  6. 2020 (303)

More Years

Publications
  1. Blood (234)
  2. Cancer Research (174)
  3. Journal of Clinical Oncology (129)
  4. Clinical Cancer Research (105)
  5. Nature (96)
  6. Nature Communications (96)

More Publications

Publishers
  1. Nature Publishing Group (469)
  2. American Association for Cancer Research (379)
  3. Cell Press (280)
  4. American Society of Hematology (257)
  5. American Society of Clinical Oncology (148)
  6. Elsevier Inc. (144)

More Publishers

Results (3040)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of pancreatic cancer stem cells with tumor stroma type
    Meeting Abstract

    Sahin, I. H.; Askan, G.; Chou, J. F.; Capanu, M.; Yu, K. H.; Basturk, O.; Iacobuzio-Donahue, C. A.; O'Reilly, E. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor volumetric correlation with plasma cell free DNA (cfDNA) mutation detection in metastatic lung cancers
    Meeting Abstract

    Haseltine, J.; Offin, M.; Myers, M. L.; Makhnin, A.; Adamski, A.; Li, H.; Li, M.; Shaffer, T.; Henderson, S.; Shen, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MET inhibitor resistance in patients with MET exon 14-altered lung cancers
    Meeting Abstract

    Guo, R.; Offin, M.; Brannon, A. R.; Chow, A.; Delasos, L.; Somwar, R.; Wilkins, O.; Scott, K.; Tian, Y.; Cecchi, F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • KRAS and TP53 status as a predictor of survival in patients with resected pancreatic ductal adenocarcinoma
    Meeting Abstract

    McIntyre, C. A.; Lawrence, S. A.; Wong, W.; Chou, J. F.; Capanu, M.; Berger, M. F.; Allen, P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical validation of a genomics-based classifier to predict tissue of origin from targeted tumor sequencing
    Meeting Abstract

    Zheng, Y.; Penson, A. V.; Camacho, N.; Biederstedt, E.; Zehir, A.; Kandoth, C.; Syed, A.; Varghese, A. M.; Al-Ahmadie, H. A.; Schultz, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • ARID1A is a critical regulator of luminal identity and therapeutic response in estrogen receptor-positive breast cancer
    Meeting Abstract

    Toska, E.; Xu, G.; Chhangawala, S.; Cocco, E.; Razavi, P.; Otto, J.; Cai, Y.; Chan, C.; D'Avino, D. R.; Collings, C.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Genomic profiling of metastatic breast cancer identifies the Hippo pathway to be a key determinant of CDK4/6 inhibitor sensitivity
    Meeting Abstract

    Razavi, P.; Li, Q.; Li, Z.; Brown, D. N.; Ping, C.; Shen, R.; Sanchez-Vega, F.; Schultz, N. D.; Baselga, J.; Scaltriti, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save